Prostate Cancer Research in Europe European Union Prostate Cancer Research Framework Program (FP) 6 FP6 funded projects in fiscal years 2004/2005 Total.

Slides:



Advertisements
Similar presentations
Annual Growth Survey What is the AGS? A communication, which sets out the economic and social priorities for the EU in 2013 Launches the next European.
Advertisements

The future of EU research Rudolf Meijer, European Commission Prague, 26 May 2004 Annex X.
European Science Advisory Network for Health (EuSANH) Improving Science Advice for Health in Europe The EuSANH-ISA project is supported by funding under.
7 th Framework Programme (FP7) - Malta’s participation th January 2013 Anthea Fabri FP7 National Coordinator Malta Council for Science and.
Head of European Research & Innovation University College London
Prof. Vincent Rollet, Taiwan Health NCP Info Day, National Cheng Kung University 06 July 2012, Tainan, Taiwan EU FP7 at Glance & 2013 Health Working Program.
EU RTD + FP Cancer Treatment: A priority for patients in Europe 7 th European Health Forum Bad Gastein 7 October, 2004 Cornelius Schmaltz MD European.
NCI Designation: Expanding Science and Promoting Health in the Region Name Title, Company Date.
EU Research and Innovation Policy
The copyright © is owned by the author of this document. Please do not duplicate. Disclaimer: the „Fit for Health project partners.
UNIVERSITY OF LJUBLJANA. UNIVERSITY HISTORY Established in faculties -3 academies -1 university college -A traditional, comprehensive and research.
Companies and the Sixth Framework Programme. Agenda Overview of the 6 th Framework Programme (FP6) Why participate ? Industry participation in FP6 What’s.
Budget /14/2015 ©European Commission 1 B udget 2011 Spending Priorities Laying the cornerstone for smart, sustainable and inclusive growth Jan Gerritsen.
Raising EU R&D Intensity Evidences from the Report for the European Commission by an Independent Research Group Ana Paiva Inês Costa Science and Technology.
FP 6- Thematic Priority 4 Aeronautics & Space Joseph Prieur - Aeronautics DG Research- Space &Transport.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
MUNROS is funded by the European Commission FP7 programme Leads: Christine Bond and Bob Elliott University of.
Supplemental Capital Budgeting Request 1 Board of Trustees Finance & Audit Committee Meeting December 15, 2014.
The future prospects for clinical trials in Europe Richard Torbett Chief Economist, EFPIA.
BB Horizon 2020! November 21, 2013 Rob Hartman Faster, smaller, greener.
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
RECOMMEND 2 nd Working Summit 26 – 28 November 2012 Neil Darwin, Chief Executive Opportunity Peterborough.
September 13, 2007SGH&M2B International&Training Workshop What does the European Technology Platform “Innovative Medicines initiative” offer? Vitalijs.
MUNROS is funded by the European Commission FP7 programme MUNROS is funded by the European Commission FP7 programme,
Research and Innovation Research and Innovation EU RESEARCH GRANTS WORKSHOP ON ‘LEADING IN RESEARCH DEVELOPMENT ACTIVITIES FOR HIGHER EDUCATION’
R&D IN HUNGARY National Research and Technological Innovation Fund Independent central government office responsible for R&D Expected new budget: approx.
ANZ Clinical Trials - What is the Future? Session Chair: Michael Quinn.
ResearchEuropean Commission FP 6 - Thematic Priority 1 International co-operation.
Three Horizon2020 priorities: 1.Excellent science 2.Industrial leadership 3.Societal challenges.
Фондация ГИС Трансфер Център г. Sofia Лектор: Kostadin Kostadiov Проект: EURESP+, ENT/CIP/10/D/
The Innovative Medicines Initiative A winning case for Joint Technology Initiative Status.
Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.
Public health research in Europe Mark McCarthy (University College London) Levels of health sciences molecules cells organs people populations Laboratory.
Gross Domestic Product. What is Gross Domestic Product? The total market value of all final goods and services produced during a given period of time.
EURORDIS Eurordis Position on Research Priorities for Rare Diseases.
Horizon th May 2014 NOVI SAD Laslo Šamu MSc. Project manager at OUS.
FP7 – Nov Towards the EU Seventh Framework Programme (FP7) European Commission Research DG.
A STRONG PATIENTS’ VOICE TO DRIVE BETTER HEALTH IN EUROPE EPF Annual General Meeting 19 May 2010 EPF Annual General Meeting 19 May 2010.
The EU framework programme for research and innovation.
1 EUROPEAN INNOVATION POLICY: Innovation policy: updating the Union’s approach in the context of the Lisbon strategy Thursday, 9 October 2003 Sofia, Bulgaria.
The impact on practice, costs and outcomes of New Roles for health professionals in Europe (MUNROS) Antoinette de Bont Erasmus University Rotterdam European.
MUNROS is funded by the European Commission FP7 programme MUNROS is funded by the European Commission FP7 programme,
Sources of Campaign Money Presidential Primaries Part private, part public money Federal matching funds for all individuals’ donations of $250 or less.
Connecting you to Industry Carol Brady Project Manager Enterprise Europe Network Galway.
Key Enabling Technologies Conditions and Opportunities for US-EU Cooperation George W. Handy Managing Director Activity for Innovation and Economic Growth.
Research and Innovation Research and Innovation I Foro Panamá – Unión Europea Piero Venturi Counsellor for Research and Innovation EU Delegation to Brazil.
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
The European Union.  “United in Diversity” is the slogan  27 Member States (Primarily in Europe)  Economic and Political Union  Operated by a Parliament.
Unit 3 – Parties, Interest Groups and Public Policy.
How to empower Polish patients - experience from the Euro Health Consumer Index (EHCI) Johan Hjertqvist Founder & President, HCP Ltd.
Research and Innovation Research and Innovation Research and Innovation Research and Innovation Horizon 2020 The EU Framework Programme for Research and.
European-Comparative Effectiveness Research on online Depression Treatment E-COMPARED is funded by the European Community’s Seventh Framework.
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Promoting new measures for the protection of women workers with oncological conditions Fight against cancer and protection of workers with oncological.
EU. IATEVAD- ECVET Units as Initial or Additional Training to the European Veterinary Assistant Diploma Pets in France 2016 – 1 – LV01-KA202 –
ASEAN FP7 Participation
From the Lisbon Agenda to Europe 2020 Gerard de Graaf
Clinical trial matching.
سرطان الثدي Breast Cancer
European Union – Russia Brokerage Event
Roberto Barcellan European Commission - Eurostat
European Union.
The European economy: stronger together
An investment plan for Europe
4 PRIORITY ISSUES 1. New genomic technologies in germinal cells ?
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Cohesion Policy and Small Businesses – The launch pad for SMEs Prof
Director «Components & Systems»
Presentation transcript:

Prostate Cancer Research in Europe European Union Prostate Cancer Research Framework Program (FP) 6 FP6 funded projects in fiscal years 2004/2005 Total life science, genomics and biotechnology for health:2.255 million Euro Prostate cancer25.5 million Euro (8 projects)= 1.13% Breast cancer71.0 million Euro (27 projects)= 3.19%

Analysis 1. Funding for independent clinical and basic science research Comparison of current spending: Germany2million Euro per annum EU26million Euro per annum USA400million Euro per annum There is never no money, just wrong priorities!

2. Clinical trial registers do not exist cannot be looked at are incompatible Example Germany: 22 trials in BPS register 20 trials in NCI register Only 6 of those trials appear in both registers

3. Patient advocacy in research and clinical trials Exists in the USA as a program of the NCI Few patients are members of ethics commissions in Germany What is happening in Europe?

1. Research management unit at European level Efficiency Economy Pace Results Recommendations

2. Funds and Finances for prostate cancer research EU: match breast cancer research funding – 71 million National EU member states: match EU funding – 71 million Private and industry donations: match EU funding – 71 million

Make both recommendations UOMO top priorities ! ! !